170 related articles for article (PubMed ID: 17941284)
21. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
[TBL] [Abstract][Full Text] [Related]
22. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
[TBL] [Abstract][Full Text] [Related]
23. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
Krishna R; Krishnaswami S; Kittner B; Sankoh AJ; Jensen BK
Biopharm Drug Dispos; 2004 Dec; 25(9):373-87. PubMed ID: 15517550
[TBL] [Abstract][Full Text] [Related]
24. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
Russell T; Stoltz M; Weir S
Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
[TBL] [Abstract][Full Text] [Related]
27. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance.
Vermeeren A; O'Hanlon JF
J Allergy Clin Immunol; 1998 Mar; 101(3):306-11. PubMed ID: 9525444
[TBL] [Abstract][Full Text] [Related]
28. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension.
Weinstein S; Qaqundah P; Georges G; Nayak A
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):339-47. PubMed ID: 19441606
[TBL] [Abstract][Full Text] [Related]
30. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
[TBL] [Abstract][Full Text] [Related]
31. The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis.
Ngamphaiboon J; Direkwattanachai C; Visitsunthorn N; Vangveeravong M; Tiensuwan M
Asian Pac J Allergy Immunol; 2005 Dec; 23(4):169-74. PubMed ID: 16572735
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of fexofenadine in the prophylactic control of cat allergen-induced allergic rhinitis.
Berkowitz RB; Braker S; Lutz C; Jones P; Meeves S; Qiu C; Varghese ST; Georges G
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):327-33. PubMed ID: 16498855
[TBL] [Abstract][Full Text] [Related]
33. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
Gradman J; Caldwell MF; Wolthers OD
Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
[TBL] [Abstract][Full Text] [Related]
34. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.
Potter PC;
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):175-80. PubMed ID: 16136768
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis.
Cingi C; Gunhan K; Gage-White L; Unlu H
Laryngoscope; 2010 Sep; 120(9):1718-23. PubMed ID: 20717951
[TBL] [Abstract][Full Text] [Related]
37. A comparative study of the efficacy and safety of loratadine syrup and terfenadine suspension in the treatment of 3- to 6-year-old children with seasonal allergic rhinitis.
Lutsky BN; Klöse P; Melon J; Menardo JL; Molkhou P; Ronchetti R; Suonpää J; Wahn U; Wessel F
Clin Ther; 1993; 15(5):855-65. PubMed ID: 8269452
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
39. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit.
Day JH; Briscoe MP; Welsh A; Smith JN; Clark A; Ellis AK; Mason J
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):533-40. PubMed ID: 9433370
[TBL] [Abstract][Full Text] [Related]
40. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
Compalati E; Baena-Cagnani R; Penagos M; Badellino H; Braido F; Gómez RM; Canonica GW; Baena-Cagnani CE
Int Arch Allergy Immunol; 2011; 156(1):1-15. PubMed ID: 21969990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
